Evidence map›Paper›PMID 42885400›Full record

ArticleChemical biology & drug design2026

DNAzymes and Oligodeoxyribonucleotides Immobilized on Aminopropylsilanol and Polylysine-Anatase Nanoparticles as Active Agents Against Influenza A/H5N1 Virus.

Marina Repkova, Asya Levina, Ekaterina Filippova, Elena Makarevich, Maria Protsenko, Larisa Shishkina, Artemiy Sergeev, Valentina Zarytova

Abstract read
PubMed Publisher
In one paragraph

Article in Chemical biology & drug design, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Marina RepkovaInstitute of Chemical Biology and Fundamental Medicine, SB RAS, Novosibirsk, Russia.ORCID https://orcid.org/0000-0002-7108-9036
Asya LevinaInstitute of Chemical Biology and Fundamental Medicine, SB RAS, Novosibirsk, Russia.ORCID https://orcid.org/0000-0003-2423-3805
Ekaterina FilippovaFBRI State Research Center of Virology and Biotechnology "Vector" of Rospotrebnadzor, Koltsovo, Novosibirsk Region, Russia.
Elena MakarevichFBRI State Research Center of Virology and Biotechnology "Vector" of Rospotrebnadzor, Koltsovo, Novosibirsk Region, Russia.
Maria ProtsenkoFBRI State Research Center of Virology and Biotechnology "Vector" of Rospotrebnadzor, Koltsovo, Novosibirsk Region, Russia.
Larisa ShishkinaFBRI State Research Center of Virology and Biotechnology "Vector" of Rospotrebnadzor, Koltsovo, Novosibirsk Region, Russia.
Artemiy SergeevFBRI State Research Center of Virology and Biotechnology "Vector" of Rospotrebnadzor, Koltsovo, Novosibirsk Region, Russia.
Valentina ZarytovaInstitute of Chemical Biology and Fundamental Medicine, SB RAS, Novosibirsk, Russia.ORCID https://orcid.org/0000-0002-9579-9972

Funding

Russian state-funded project for ICBFM SB RAS 125012300656-5State Research Center of Virology and Biotechnology "Vector," Russia 24/26-3.3.1
6 · The paper itself

Abstract

The nanocomposites based on aminopropylsilanol (Si~NH

Indexed as

Antiviral AgentsInfluenza A Virus, H5N1 SubtypeNanoparticlesOligodeoxyribonucleotidesPolylysineSilanesAnimalsDogsHumansMadin Darby Canine Kidney CellsNanocompositesVirus ReplicationAntiviral AgentsOligodeoxyribonucleotidesPolylysineSilanesanatase and aminopropylsilanol nanoparticlesDNAzymesinhibition of influenza A/H5N1 virusnanocompositesoligodeoxyribonucleotides

Identifiers

PMID42885400

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.